Zogenix, inc. (ZGNX)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flow from operating activities:
Net loss

-410,101

-419,503

-385,876

-137,662

-128,936

-123,914

-141,189

-141,719

-135,690

-126,817

-110,601

-84,804

-80,625

-69,707

-55,057

-52,676

38,616

26,144

14,465

16,256

6,658

8,587

-6,508

-4,534

-80,733

-80,856

-45,883

-54,314

-58,149

-47,386

-70,447

-73,203

-75,212

-83,903

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

23,418

21,247

18,556

20,102

17,803

15,492

14,041

8,322

6,394

6,155

6,216

6,895

7,538

7,353

6,908

6,330

7,303

7,686

8,139

8,818

8,856

9,492

9,962

10,135

9,128

8,207

7,198

6,727

6,487

6,157

5,845

5,420

5,114

4,809

0

0

0

Depreciation and amortization

1,466

1,300

1,034

702

368

200

68

84

210

400

842

1,072

1,235

1,400

1,353

1,501

1,606

1,621

1,632

1,619

1,612

1,625

1,638

1,681

1,733

1,806

1,822

1,754

1,685

1,599

1,564

1,583

1,586

1,584

0

0

0

Noncash lease expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs and debt discount

-

-

-

-

-

-

-

-

-

887

790

820

986

991

1,061

987

791

791

771

651

553

457

517

580

597

569

541

1,496

1,469

2,017

2,402

1,808

2,132

1,793

0

0

0

Net accretion and amortization of investments in marketable securities

3,399

4,887

5,972

5,297

3,701

1,998

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liabilities

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquired in-process research and development expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of embedded derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-14

-167

1,307

826

759

599

-1,077

-266

-147

-211

128

-202

-240

0

0

0

Change in fair value of common stock warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-9,327

-5,387

7,112

7,171

5,220

1,103

-52,611

-44,366

-33,191

-25,332

51,125

43,392

34,454

21,927

-18,202

-14,848

-16,020

-11,811

2,620

-403

-494

-445

0

0

0

Change in fair value of contingent consideration

-5,300

5,600

800

6,100

4,300

1,300

15,700

20,500

23,500

24,100

10,600

300

1,100

1,800

2,700

2,200

300

-2,000

-1,900

-1,600

-1,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Asset impairment charges

-

-

-

-

-

-

-

-

-

1,116

9,547

9,351

9,244

8,431

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

0

-

-

-

0

-

-

-

2,194

-9,356

-3,299

2,576

-3,873

11,181

2,565

-4,206

234

-7,477

-1,927

398

-7,010

2,212

-275

1,782

5,925

1,022

657

-756

812

730

2,503

1,676

1,224

439

0

0

0

Other receivable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-

-

-

-

-

-

-

-

-

-2,583

-4,933

-7,380

-345

-4,983

-998

-1,038

-4,430

-1,394

-8,861

-2,759

-965

3,503

7,182

2,471

2,191

-2,950

-2,141

-2,354

-2,118

-3,890

-5,152

-3,017

-3,471

-1,517

0

0

0

Prepaid expenses, escrow holdback and other current assets

-1,581

-7,573

28,820

-218

4,231

9,335

4,368

6,885

861

801

-5,465

-1,346

2,317

3,394

2,214

-705

-352

650

904

3,315

11,935

9,200

13,081

11,592

95

2,004

-1,114

-633

433

-163

626

132

517

-24

0

0

0

Other assets

0

-

-

-

-

-266

0

0

0

-

-

-

-

-471

822

1,716

1,593

-316

-1,851

-1,729

4,213

4,126

7,339

7,240

2,702

1,747

-911

-935

-629

-11

-265

146

-100

-338

0

0

0

Accounts payable, accrued and other liabilities

8,308

5,647

25,945

-337

-1,442

6,545

1,599

5,879

7,756

4,340

6,839

2,283

-5

-1,778

-7,040

-8,267

-19,477

-14,232

-8,578

-15,138

-586

5,404

8,318

17,396

13,144

6,146

3,155

-222

1,681

2,194

4,671

7,631

8,447

4,898

0

0

0

Operating lease liability

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-3,397

13,352

13,801

14,431

15,500

0

0

0

-972

-1,245

-6,072

-5,891

-4,786

-5,839

-1,841

-4,244

-7,389

-8,464

-8,738

-5,745

7,294

15,658

16,624

15,853

5,826

-137

0

0

0

-8,462

-10,938

-13,231

-15,971

-10,887

0

0

0

Deferred rent and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

0

0

0

0

Net cash used in operating activities

0

-

-

-

-

-111,658

-112,675

-105,449

-89,240

-75,874

-64,932

-62,443

-62,881

-72,880

-68,133

-58,157

-64,071

-64,602

-60,424

-82,986

-79,939

-80,816

-81,975

-61,054

-52,670

-44,920

-42,683

-47,306

-52,554

-52,202

-59,944

-69,430

-72,351

-80,471

0

0

0

Cash flows from investing activities:
Cash paid for in-process research and development asset

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

199,510

329,641

502,105

821,297

715,341

569,515

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of marketable securities

298,400

415,020

490,128

415,140

297,008

125,783

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

5,150

9,492

10,527

9,856

5,488

1,018

116

125

115

76

35

39

46

103

197

339

337

308

251

273

161

122

110

-71

-5

810

823

800

1,012

293

446

542

609

617

0

0

0

Net cash provided by investing activities

89,474

73,121

-25,276

-416,013

-423,821

-444,750

-375,728

-125

-115

-76

-10,037

-10,041

-46

-103

16,233

16,090

85,516

85,545

59,174

59,153

60,963

61,002

81,014

81,195

5

-810

-823

-800

-1,012

-293

-446

-542

-609

-617

0

0

0

Cash flows from financing activities:
Payment of contingent consideration

10,000

20,000

10,000

10,000

10,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

-

-

-

0

0

0

-

-

-

-

Repayment of revolving credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from revolving credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Principal repayments of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

3,334

4,784

4,784

3,116

1,450

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from issuance of common stock under equity incentive plans

7,843

10,182

11,304

10,253

10,443

9,654

15,654

14,366

12,766

9,176

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

27

80

80

92

0

0

0

Taxes paid related to net share settlement of equity awards

731

744

662

610

1,720

1,430

1,426

1,426

292

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

0

0

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

264,284

42,576

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

92,210

91,182

-826

-943

556

77,198

77,198

77,192

75,690

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

261,396

32,014

642

292,528

321,858

331,359

586,711

311,916

281,200

277,902

19,831

446

849

-817

-917

92,492

89,425

92,201

113,406

19,970

-10,394

-10,002

34,136

44,973

78,025

76,523

11,306

42,253

39,046

37,198

39,095

84,274

86,544

88,441

0

0

0

Net decrease in cash and cash equivalents

211,687

-6,384

-129,939

-221,315

-213,665

-225,049

98,308

206,342

191,845

201,952

-55,138

-72,038

-62,078

-73,800

-52,817

50,425

110,870

113,144

112,156

-3,863

-29,370

-29,816

33,175

65,114

25,360

30,793

-32,200

-5,853

-14,520

-15,297

-21,295

14,302

13,584

7,353

0

0

0

Noncash investing and financing activities:
Extinguishment of note payable advanced by a customer under a contract manufacturing supply agreement through net settlement of our receivables from the customer

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Purchases of property and equipment in accounts payable and accrued liabilities

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-